Sep 8, 2021 | Science, Services
A Decade of De Novo Antibody Sequencing Experience De novo antibody sequencing experience Have you lost your hybridoma? Is your hybridoma no longer producing? Is your hybridoma producing more than your desired antibody? Do you have a monoclonal antibody from a...
Jul 22, 2021 | Publications, Science, Services
New Publication Reveals Ebolavirus-Neutralizing Monoclonal Antibodies Abterra Biosciences, together with VUMC Vaccine Center, Mapp Bio, PNNL, UTMB Health, Ragon Institute, Integral Molecular, and La Jolla Institute, recently published a paper describing the discovery...
Jul 13, 2021 | Science, Services
Immune Repertoire Sequencing in Human Immune repertoire sequencing enables deeper understanding of the adaptive immune response [1]. Abterra Biosciences has developed Reptor™, a flexible immune repertoire sequencing and analysis service. In this study, we analyzed...
Jun 6, 2021 | Science, Services
Clonal Hit-Expansion Case Study Abterra Bio uses next-generation sequencing to mine the clonal lineage of serum-identified antibodies. This method rescues relatives of hits that are within a clone and increases diversity in your antibody discovery campaign. Contact...
Jun 6, 2021 | Science, Services
Llama Immune Repertoire Profiling Alicanto® is Abterra Biosciences’ proprietary antibody discovery platform that mines the entire immune response to identify diverse, functional antibodies. For an overview of the proteogenomic process, read more about Alicanto®....
Jan 20, 2021 | Science, Services
Alicanto Antibody Discovery – Diversity Alicanto® is Abterra Biosciences’ proprietary antibody discovery platform that mines the entire immune response to identify diverse, functional antibodies. For an overview of the proteogenomic process, read more...
